Dr. Kim is a Professor of Neurosurgery at The University of Texas MD Anderson Cancer Center. After completing her medical degree from McMaster University in Montreal, she completed her doctorate in Biomaterials and Biomedical Engineering from the University of Toronto followed by a Research Fellowship in Neurologic Surgery from Brigham and Women's Hospital Clinical Residency, Neurosurgery in 2001, a Clinical Residency in Neurosurgery from the University of Ottawa in 2005, a Clinician Investigator Program in Neurologic Surgery from the University of Toronto, and Clinical Fellowships in Neurosurgical Oncology and in Skull Base Surgery from The University of Texas MD Anderson Cancer Center in 2012 and 2013, respectively. In 2012, she was named Fellow of The Royal College of Physicians of Canada and obtained Clinician Investigator Program Certification. Dr. Kim’s clinical practice focuses on the management of primary and secondary central nervous system malignancies. As a physician-scientist, she uses a multidisciplinary approach to research solid tumors with a specific focus on malignant primary and metastatic brain tumors. Her laboratory seeks to understand the mechanisms of innate immune regulation in cancer and works to develop novel and effective therapies that boost the functions of innate immune system to eliminate malignant tumors. Applying state-of-art tools in material engineering, optical imaging and protein engineering, Dr. Kim’s lab is studying how synthetic nanomaterials can be designed in ways that can facilitate the recognition and clearance of tumor cell by the body’s immune system. Dr. Kim’s research has been funded by multiple R01 grants from National Institute of Neurological Disorders and Stroke, National Cancer Institute, and National Institute of General Medicine Sciences, as well as a Breakthrough Award from the Department of Defense. Dr. Kim is an elected fellow of the American Institute for Medical and Biological Engineering.